Cargando…
Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors
Breast carcinoma is the most common malignancy among women and it has a major impact on mortality. Studies of primary chemoprevention with tamoxifen have generated high expectations and considerable success rates. The efficacy of lower doses of tamoxifen is similar to that seen with a standard dose...
Autores principales: | de Sousa, Juarez Antônio, Facina, Gil, da Silva, Benedito Borges, Gebrim, Luiz Henrique |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1578575/ https://www.ncbi.nlm.nih.gov/pubmed/16972993 http://dx.doi.org/10.1186/1477-7800-3-29 |
Ejemplares similares
-
Analysis of the Ki-67 index in the vaginal epithelium of castrated rats treated with tamoxifen
por: Nery-Aguiar, Afif Rieth, et al.
Publicado: (2016) -
Expression of estrogen and progesterone receptors in astrocytomas: a literature review
por: Tavares, Cléciton Braga, et al.
Publicado: (2016) -
Effects of anastrozole on Ki-67 antigen expression in the vaginal epithelium of female rats in persistent estrus
por: Chagas, Diego Cipriano, et al.
Publicado: (2020) -
Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
por: Clarke, R. B., et al.
Publicado: (1993) -
Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer
por: Oh, Hannah, et al.
Publicado: (2016)